MF

Malek Faham

Chief Scientist at Illumina Ventures

San Francisco Bay Area

Overview 

Malek Faham is an accomplished inventor and entrepreneur based in the San Francisco Bay Area, known for his roles as Chief Scientist at Illumina Ventures and Co-Founder of Vineti. With a background in medicine and research, Faham has made significant contributions to the fields of diagnostics, biotech, and health IT throughout his career. Highlights of Faham's career include co-founding Sequenta Inc, which was later acquired by Adaptive Biotechnologies, and serving as Chief Scientific Officer at AccuraGen. These roles demonstrate his expertise in leading successful ventures and driving innovation in the healthcare industry.

Work Experience 

Illumina Ventures

  • Chief Scientist

    2017 - Current

A

AccuraGen

  • Chief Scientific Officer

    2015

A cancer early detection company

Raised $40,000,000.00 from Decheng Capital, Temasek Holdings, Nan Fung Group, DT Capital Partners, StartX (Stanford-StartX Fund) and Junson Capital.

accuragen.com
V

Vineti

  • Co-Founder and Advisor

    2016 - 2019

Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.

Raised $115,250,000.00 from McKesson Ventures, Marc Benioff, Threshold, Novartis Pharma, Casdin Capital, Cardinal Health, Lifeforce Capital, Canaan Partners, Section 32 and Threshold.

vineti.com

Convergent Genomics

  • Scientific Advisor

    2015 - 2019

SI

Sequenta Inc (acquired by Adaptive Biotechnologies in 2015)

  • Co-Founder and Chief Scientific Officer

    2008 - 2016

Sequenta is engaged in the discovery and development of clinical diagnostics based on a platform for understanding immune system status.

Raised $43,460,000.00 from Celgene, Index Ventures, Farzad Nazem and Mohr Davidow Ventures.

sequenta.com
A

Affymetrix

  • VP, Oncology Technology Research

    2005 - 2008

Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell,

affymetrix.com

ParAllele BioScience (acquired by Affymetrix in 2005)

  • Co-Founder and Director of Research

    2001 - 2005

Stanford University (Genome Technology Center)

  • Research Associate

    2000 - 2002

Psychiatry department at University of California San Francisco

  • Resident

    1997 - 2001

Education 

Articles About Malek

Relevant Websites